UR Home
![]() | Up a level |
Klug, Maja, Schmidhofer, Sandra, Gebhard, Claudia, Andreesen, Reinhard and Rehli, Michael
(2013)
5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes.
Genome biology 14 (5), R46.
, Park, Moon-Ho and Jo, Inho
(2012)
DNA methylation of the 5′-untranslated region at +298 and +351 represses BACE1 expression in mouse BV-2 microglial cells.
Biochemical and Biophysical Research Communications 417 (1), pp. 387-392.
Fulltext not available.
Klug, Maja
(2010)
Dynamics of DNA methylation in differentiating hematopoietic cells.
PhD, Universität Regensburg.
, Gebhard, Claudia, Schwarzfischer, Lucia, Krause, Stefan W
, Andreesen, Reinhard and Rehli, Michael
(2010)
Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels.
Genome Biology 11 (6).
Fulltext not available.
(2010)
General Transcription Factor Binding at CpG Islands in Normal Cells Correlates with Resistance to De novo DNA Methylation in Cancer Cells.
Cancer Research 70 (4), pp. 1398-1407.
Fulltext not available.
and Rehli, Michael
(2009)
Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity.
Genome Research 19 (7), pp. 1165-1174.
Fulltext not available.
and Rehli, Michael
(2007)
CCAAT Enhancer-binding Protein β Regulates Constitutive Gene Expression during Late Stages of Monocyte to Macrophage Differentiation.
Journal of Biological Chemistry 282 (30), pp. 21924-21933.
Fulltext not available.
, Weber, Bernhard H. F.
and make_name_string expected hash reference
(2007)
Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
Journal of Leukocyte Biology (JLB) 82, pp. 1564-1574.
Fulltext not available.
(2006)
Functional Analysis of Promoter CPG-Methylation using a CpG-Free Luciferase Reporter Vector.
Epigenetics 1 (3), pp. 127-130.
Fulltext not available.
(2006)
Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Cancer research 66 (12), pp. 6118-28.
Fulltext not available.
Publication Server
Publishing: oa@ur.de
0941 943 -4239 or -69394
Dissertations: dissertationen@ur.de
0941 943 -3904
Research data: datahub@ur.de
0941 943 -5707